Vanda Pharmaceuticals Inc.
VNDA
$8.81
-$0.48-5.17%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 263.85M | 293.75M | 325.55M | 340.91M | 374.64M |
| Total Receivables | 54.58M | 50.54M | 44.99M | 44.60M | 47.10M |
| Inventory | 1.85M | 2.04M | 2.17M | 1.92M | 1.73M |
| Prepaid Expenses | 26.88M | 21.16M | 22.21M | 20.48M | 15.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 103.00K | -- | -- | -- | -- |
| Total Current Assets | 347.26M | 367.50M | 394.92M | 407.91M | 438.89M |
|
|
|||||
| Total Current Assets | 347.26M | 367.50M | 394.92M | 407.91M | 438.89M |
| Net Property, Plant & Equipment | 13.51M | 11.90M | 12.47M | 12.48M | 12.68M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 117.09M | 108.84M | 110.59M | 112.34M | 114.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.08M | 112.90M | 106.76M | 99.21M | 90.54M |
| Total Assets | 488.95M | 601.14M | 624.75M | 631.94M | 656.20M |
|
|
|||||
| Total Accounts Payable | 4.94M | 3.14M | 2.18M | 5.99M | 3.50M |
| Total Accrued Expenses | 47.80M | 39.79M | 50.26M | 34.90M | 31.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.56M | 4.69M | 4.68M | 4.39M | 4.27M |
| Total Finance Division Other Current Liabilities | 86.87M | 70.25M | 64.37M | 58.64M | 60.90M |
| Total Other Current Liabilities | 86.87M | 70.25M | 64.37M | 58.64M | 60.90M |
| Total Current Liabilities | 145.16M | 117.87M | 121.49M | 103.92M | 99.98M |
|
|
|||||
| Total Current Liabilities | 145.16M | 117.87M | 121.49M | 103.92M | 99.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.07M | 6.23M | 6.96M | 7.35M | 8.09M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.53M | 11.04M | 9.97M | 9.25M | 9.59M |
| Total Liabilities | 161.76M | 135.14M | 138.42M | 120.52M | 117.66M |
|
|
|||||
| Common Stock & APIC | 721.32M | 719.04M | 716.93M | 714.82M | 712.76M |
| Retained Earnings | -394.77M | -253.58M | -230.99M | -203.79M | -174.29M |
| Treasury Stock & Other | 629.00K | 540.00K | 396.00K | 383.00K | 74.00K |
| Total Common Equity | 327.19M | 466.00M | 486.33M | 511.42M | 538.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 327.19M | 466.00M | 486.33M | 511.42M | 538.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 327.19M | 466.00M | 486.33M | 511.42M | 538.55M |
|
|
|||||